ILC 2017: European countries restrict access to life-saving treatment for hepatitis C
April 20, 2017, Amsterdam, The Netherlands: Data presented today demonstrate that there are considerable restrictions in the reimbursement of direct-acting antiviral (DAA) therapy across European...






